Abiomed Inc.

NASDAQ: ABMD · Real-Time Price · USD
381.02
0.00 (0.00%)
At close: Dec 21, 2022, 10:00 PM

Abiomed Balance Sheet Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year FY 2022 FY 2021
Period Ending Mar 31, 2022 Mar 31, 2021
Cash & Equivalents
132.82M 232.71M
Short-Term Investments
625.79M 350.99M
Long-Term Investments
351.94M 365.74M
Other Long-Term Assets
n/a n/a
Receivables
90.61M 97.18M
Inventory
93.98M 81.06M
Other Current Assets
33.28M 26.03M
Total Current Assets
976.47M 787.97M
Property-Plant & Equipment
212.01M 203.24M
Goodwill & Intangibles
122.42M 126.04M
Total Long-Term Assets
696.92M 706.39M
Total Assets
1.67B 1.49B
Account Payables
35.35M 34.84M
Deferred Revenue
26.36M 24.32M
Short-Term Debt
n/a 66.05M
Other Current Liabilities
76.75M 3.76M
Total Current Liabilities
138.46M 128.97M
Long-Term Debt
n/a n/a
Other Long-Term Liabilities
30.83M 34.87M
Total Long-Term Liabilities
31.61M 35.72M
Total Liabilities
170.07M 164.68M
Total Debt
n/a n/a
Common Stock
455K 453K
Retained Earnings
964.51M 828.01M
Comprehensive Income
-27.16M -11.45M
Shareholders Equity
1.5B 1.33B
Total Investments
977.73M 716.72M